Preparation and Study of Solid Lipid Nanoparticles Based on Curcumin, Resveratrol and Capsaicin Containing Linolenic Acid

Abstract

Linolenic acid (LNA) is the most highly consumed polyunsaturated fatty acid found in the human diet. It possesses anti-inflammatory effects and the ability to reverse skin-related disorders related to its deficiency. The purpose of this work was to encapsulate LNA in solid lipid nanoparticles (SLNs) based on curcumin, resveratrol and capsaicin for the treatment of atopic dermatitis. These compounds were first esterified with oleic acid to obtain two moonoleate and one oleate ester, then they were used for SLN matrix realization through the emulsification method. The intermediates of the esterification reaction were characterized by FT-IR and 1N-MR analysis. SLNs were characterized by dimensional analysis and encapsulation efficiency. Skin permeation studies, antioxidant and anti-inflammatory activities were evaluated. LNA was released over 24 h from nanoparticles, and resveratrol monooleate-filled SLNs exhibited a good antioxidant activity. The curcumin-based SLNs loaded or not with LNA did not induce significant cytotoxicity in NCTC 2544 and THP-1 cells. Moreover, these SLNs loaded with LNA inhibited the production of IL-6 in NCTC 2544 cells. Overall, our data demonstrate that the synthesized SLNs could represent an efficacious way to deliver LNA to skin cells and to preserve the anti-inflammatory properties of LNA for the topical adjuvant treatment of atopic dermatitis.

Potential Oral Anticancer Therapeutic Agents of Hexahydrocurcumin-Encapsulated Chitosan Nanoparticles against MDA-MB-231 Breast Cancer Cells

“…Surfactants such as sodium lauryl sulfate (SLS), cetyltrimethylammonium bromide (CTAB), or polysorbate 80 and organic solvents such as ethanol, isopropyl alcohol, or acetone) are typically added to release media to enhance the drug solubility of the sink condition in in vitro drug release tests [ 61 ]. Several recent studies have reported the use of different release media containing ethanol up to 50% ( v / v ) to investigate the release profile of hydrophobic drugs [ 62 , 63 , 64 , 65 , 66 , 67 , 68 , 69 , 70 , 71 , 72 , 73 ]. Nasra et al [ 64 ] reported that the release medium containing 50% ( v / v ) ethanol is the most suitable for curcumin release (100% release) compared to the other release media containing various types of surfactants such as 0.5–1% w / v SLS or 30% w / v polyethylene glycol 400 (PEG 400).…”

Solid Lipid Nanoparticles Hydroquinone-Based for the Treatment of Melanoma: Efficacy and Safety Studies

“…The fabrication of solid lipid nanoparticles can be carried out by microemulsification, which consists of the initial mixing of the hot ester with the surfactants (Tween 20, butanol and sodium taurocholate) at 70 °C. The nanoparticles are formed by dispersing the resulting mixture in cold water under mechanical agitation at high speed [ 24 ]. The substances used are reported in Table 1 .…”

Nutraceutical-Based Nanoformulations for Breast and Ovarian Cancer Treatment

“…In the past, we explored whether combinations of nutraceuticals, known for their anti-inflammatory and/or antineoplastic activities with conventional or innovative anticancer drugs, could potentially enhance the drug effects and ameliorate the physical conditions of patients [ 8 , 9 , 10 , 11 , 12 ]. Most recently, we have also investigated the possibility of improving the action of nutraceuticals or anticancer drugs through their inclusion in nanomaterials with the potential to protect and, more specifically, deliver them to tissues affected by pathological processes [ 13 , 14 , 15 , 16 , 17 , 18 ]. The strategy of administrating bioactive drugs and/or nutraceuticals in nanoformulations has recently attracted considerable interest worldwide [ 19 ].…”